MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 116 filers reported holding MAXCYTE INC in Q2 2023. The put-call ratio across all filers is 4.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $60,122 | -69.5% | 19,270 | -55.2% | 0.00% | – |
Q2 2023 | $197,439 | -68.6% | 43,015 | -66.2% | 0.00% | – |
Q1 2023 | $629,294 | +31.4% | 127,130 | +44.9% | 0.00% | – |
Q4 2022 | $478,902 | -39.5% | 87,711 | -27.9% | 0.00% | – |
Q3 2022 | $791,000 | +853.0% | 121,679 | +593.0% | 0.00% | – |
Q2 2022 | $83,000 | +13.7% | 17,559 | +67.3% | 0.00% | – |
Q1 2022 | $73,000 | -74.8% | 10,498 | -63.1% | 0.00% | – |
Q4 2021 | $290,000 | – | 28,440 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |